This inventor holds 2 USPTO granted patents and 7 published patent applications. Top assignees: Pf Argentum IP Holdings LLC, Pfizer Corporation. Active years: 2022-2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022-2023
Title: Natasja Nielsen Viller: Innovator in Cancer Therapy
Introduction
Natasja Nielsen Viller is a prominent inventor based in Oakville, CA. She has made significant contributions to the field of cancer therapy, holding 2 patents that focus on innovative treatment methods for blood cancers.
Latest Patents
One of her latest patents is centered around CD47 blockade therapy by HDAC inhibitors. This therapy involves treating CD47-disease cells, such as cancer cells, using a combination of a CD47 blockade drug and a histone deacetylase (HDAC) inhibitor. The anti-cancer effect of one drug enhances the anti-cancer effect of the other. Specific combinations include SIRPαFc as the CD47 blockade drug, along with either depsipeptide or romidepsin as the HDAC inhibitor. These combinations are particularly useful for treating blood cancers, including lymphomas, leukemias, and myelomas.
Another significant patent focuses on the enhancement of CD47 blockade therapy by proteasome inhibitors. In this approach, CD47-disease cells are treated using a combination of a CD47 blockade drug and a proteasome inhibitor. Similar to her previous patent, the anti-cancer effect of one drug enhances the effect of the other. Specific combinations include SIRPαFc as the CD47 blockade drug, along with bortezomib, ixazomib, or carfilzomib as the proteasome inhibitor. These combinations are also particularly effective in treating blood cancers.
Career Highlights
Natasja has worked with notable companies in the pharmaceutical industry, including Pfizer Corporation and Pf Argentum IP Holdings LLC. Her experience in these organizations has contributed to her expertise in developing innovative cancer therapies.
Collaborations
Throughout her career, Natasja has collaborated with talented individuals such as Emma Linderoth and Robert Adam Uger. These collaborations have further enriched her work and contributed to her success in the field.
Conclusion
Natasja Nielsen Viller is a dedicated inventor whose work in cancer therapy is making a significant impact. Her innovative approaches to treating blood cancers through CD47 blockade therapies demonstrate her commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile